Invesco
HUMA icon

Invesco’s Humacyte HUMA Stock Holding History

Invesco’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199K Buy
255,534
+83,099
+48% +$77K ﹤0.01% 3597
2026
Q1 		$105K Buy
172,435
+133,611
+344% +$139K ﹤0.01% 3617
2025
Q4 		$37.3K Buy
38,824
+5,079
+15% +$7.19K ﹤0.01% 3726
2025
Q3 		$58.7K Buy
33,745
+3,952
+13% +$7.74K ﹤0.01% 3736
2025
Q2 		$62.3K Sell
29,793
-352
-1% -$676 ﹤0.01% 3708
2025
Q1 		$51.4K Sell
30,145
-782
-3% -$2.94K ﹤0.01% 3695
2024
Q4 		$156K Buy
30,927
+1,438
+5% +$7.12K ﹤0.01% 3557
2024
Q3 		$160K Buy
29,489
+3,239
+12% +$21.4K ﹤0.01% 3556
2024
Q2 		$126K Buy
26,250
+4,301
+20% +$22.4K ﹤0.01% 3720
2024
Q1 		$68.3K Buy
21,949
+856
+4% +$2.88K ﹤0.01% 3780
2023
Q4 		$59.9K Sell
21,093
-2,551
-11% -$6.55K ﹤0.01% 3738
2023
Q3 		$69.3K Buy
23,644
+60
+0.3% +$199 ﹤0.01% 3770
2023
Q2 		$67.5K Buy
23,584
+336
+1% +$1.21K ﹤0.01% 3789
2023
Q1 		$71.8K Sell
23,248
-3,133
-12% -$8.91K ﹤0.01% 3731
2022
Q4 		$55.7K Buy
26,381
+6,356
+32% +$19.3K ﹤0.01% 3905
2022
Q3 		$66K Buy
20,025
+758
+4% +$2.91K ﹤0.01% 3893
2022
Q2 		$63K Buy
+19,267
New +$107K ﹤0.01% 3946

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Invesco's HUMA Position: Q2 2026 in Review

Invesco increased its Humacyte (HUMA) stake by 48% in Q2 2026, buying an estimated $77K and bringing the position to 255,534 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #3597.

Invesco first reported a position in HUMA in Q2 2022 and has held it in 17 quarters since. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Invesco held 255,534 shares of Humacyte worth $199K as of Q2 2026.
  • Invesco bought 83,099 Humacyte shares in Q2 2026, an estimated $77K.
  • Humacyte made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3597 holding.
  • Invesco first reported a position in Humacyte in Q2 2022 and has held it in 17 quarters since.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.